Zephyr AI
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $111.0Mattributed |
|---|---|
| Latest round | series-a, $111.0M, 2024-03-01attributed |
| Founded | 2020 |
| Headquarters | McLean |
| Industry | bio |
| Stage | series-a |
| Website | zephyrai.com |
Zephyr AI applies machine learning to electronic health records and multi-omic data to predict patient risk and identify optimal therapies for oncology and chronic disease. Its models are trained on real-world outcomes rather than curated trial populations, improving generalizability across diverse patient groups.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-03-01 | series-a | $111.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $111.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $111.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | zephyrai.com, read 2026-05-07 |
| Description | self-reported | zephyrai.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.